XK and influenza: Antivirals available for the treatment of influenza belong to two classes of direct-acting drugs: neuraminidase (NA) inhibitors (NAIs) targeting NA glycoprotein and the cap-dependent endonuclease inhibitor (CENI) targeting polymerase acidic (PA) protein (Jones et al., 2023).